Morita, T., Shima, Y., Fujimoto, K., Tsuboi, H., Saeki, Y., Narazaki, M., . . . Kumanogoh, A. (2019). Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis. Int Immunol.

Morita, Takayoshi, Yoshihito Shima, Kosuke Fujimoto, Hideki Tsuboi, Yukihiko Saeki, Masashi Narazaki, Atsushi Ogata, and Atsushi Kumanogoh. "Anti-receptor Activator of Nuclear Factor κB Ligand Antibody Treatment Increases Osteoclastogenesis-promoting IL-8 in Patients With Rheumatoid Arthritis." Int Immunol 2019.

Morita, Takayoshi, et al. "Anti-receptor Activator of Nuclear Factor κB Ligand Antibody Treatment Increases Osteoclastogenesis-promoting IL-8 in Patients With Rheumatoid Arthritis." Int Immunol 2019.